Project Grant HT94252510267
Award Date
9/30/25
Completion Date
9/29/28
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
College Park, MD 20742, USA
Similar Awards
The University of Maryland, College Park will receive $712,011 through a three-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support modeling and cross-sectional analysis of movement quality for service members using osseointegrated prostheses. Through June 2026, the University will conduct research to transform health care and investigate medical solutions for the battlefield....
The University of Maryland, Baltimore (UMB) was awarded a $587,271 Project Grant from the Defense Health Agency, under the Department of Defense's Military Medical Research and Development program (CFDA 12.420), to conduct research on "DUAL INHIBITION OF PARP AND IL-6 AS A NOVEL THERAPEUTIC APPROACH FOR BRCA-MUTATED TRIPLE-NEGATIVE BREAST CANCER." This research project will occur from July 1, 2024 to June 30, 2027. The Military Medical Research and Development program supports a...
The University of Maryland, Baltimore has been awarded a $1,383,874 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant, effective from March 1, 2025 to February 28, 2029, supports research to decipher the intramolecular regulatory mechanism of polycystin 1, which is implicated in polycystic kidney disease. This advanced biomedical research aims to transform healthcare for military service members, veterans, and the...
The University of Maryland, College Park was awarded a $349,778 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund an evaluation of mechanical loads on an osseointegrated implant during locomotor activities of daily living from May 2021 through May 2024. Through this funding, University of Maryland researchers will investigate how mechanical forces impact bone-implanted prosthetics during...
The Defense Health Agency awarded Duke University a $1,255,621 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to develop diagnostic and therapeutic agents targeting Borrelia burgdorferi, the causative agent of Lyme disease. The grant, with a performance period from September 15, 2024 to September 14, 2027, will enable Duke to conduct innovative biomedical research aimed at improving health outcomes for military service members and the broader public. As a...
This federal Project Grant award of $400,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, with a performance period from October 1, 2024 to September 30, 2026. The award supports research by the University of Maryland, Baltimore to develop "drug conjugates of modified LGR4/5/6 ligands for cancer treatment." The university, as the prime awardee, has extensive expertise in biomedical research, clinical trials, and...
The University of Maryland, Baltimore was awarded a $1.15 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research on BPTF-Mediated Gene Regulation in Prostate Cancer from August 1, 2022 to July 31, 2025. As part of the Military Medical Research and Development program's goal of transforming health care for service members and the public through innovative biomedical research, this project aims...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
This $1,599,997.00 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research at the University of Illinois aimed at transforming healthcare for military service members, veterans, and the broader public. The research, spanning basic, applied, and translational investigations, focuses on innovative approaches to address critical health challenges across diverse medical domains such as cancer,...